Methionine Aminopeptidases from Mycobacterium tuberculosis as Novel Antimycobacterial Targets-Reference-Cited by-同舟云学术

Methionine Aminopeptidases from Mycobacterium tuberculosis as Novel Antimycobacterial Targets

Published:2010-01 Issue:1 Volume:17 Page:86-97
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Olaleye Omonike,Raghunand Tirumalai R.,Bhat Shridhar,He Jian,Tyagi Sandeep,Lamichhane Gyanu,Gu Peihua,Zhou Jiangbing,Zhang Ying,Grosset Jacques,Bishai William R.,Liu Jun O.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference30 articles.

1. Structural basis for the functional differences between type I and type II human methionine aminopeptidases;Addlagatta;Biochemistry,2005

2. Identification of an SH3-binding motif in a new class of methionine aminopeptidases from Mycobacterium tuberculosis suggests a mode of interaction with the ribosome;Addlagatta;Biochemistry,2005

3. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes;Arfin;Proc. Natl. Acad. Sci. USA,1995

4. Methionine aminopeptidases type I and type II are essential to control cell proliferation;Bernier;J. Cell. Biochem.,2005

5. The C. elegans methionine aminopeptidase 2 analog map-2 is required for germ cell proliferation;Boxem;FEBS Lett.,2004

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes;Journal of Eukaryotic Microbiology;2024-07-22

2. ClpS directs degradation of primary N-end rule substrates inMycolicibacterium smegmatis;2024-06-13

3. Targeting Mycobacterium tuberculosis pH-driven adaptation;Microbiology;2024-05-08

4. The significance of persisters in tuberculosis drug discovery: Exploring the potential of targeting the glyoxylate shunt pathway;European Journal of Medicinal Chemistry;2024-02

5. Discovery and development of new antibacterial drugs;Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications;2024